Inovio Pharmaceuticals, Inc. (GBMB.F) FSX

0.55

+0.022(+4.15%)

Updated at January 24, 2024 09:14AM

Currency In EUR

Valuation

Market Cap1.64B
Enterprise Value1.66B
P/E Ratio-0
PEG Ratio-0.03
Price/Sales Ratio684.91
Price/Book Ratio3.2
Enterprise/Revenue609.82
Enterprise/EBITDA-0

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterDecember 31, 2023

Profitability

Profit Margin-246,264.2
Operating Margin-525.69

Management Effectiveness

Return On Assets-658.01
Return On Equity-809.7

Income Statement

Revenue832,010
Revenue/Share0
Gross Profit832,010
EBITDA-125.73M
Net Income-135.12M
Diluted EPS-0.5

Balance Sheet

Total Cash145.29M
Total Cash/Share1.22
Total Debt30.21M
Total Debt/Equity0.37
Current Ratio1.66
Book Value Per Share0.73

Price History

52-Week Change-96.36
52-Week High1.78
52-Week Low0.31
Moving Average 50 Days0.45
Moving Average 200 Days0.47

Statistics

Average Volume4,497
Shares Outstanding22.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateJune 06, 2014